Clinical Case Discussion: Intermediate-risk Prostate Cancer: The Case for Active Surveillance.
Active surveillance offers men the opportunity to defer immediate local treatment of low risk prostate cancer while preserving a highly functional quality of life. Novel biomarkers and imaging technology will enable physicians to better identify ideal candidates for this approach beyond traditional clinical characteristics.